Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for colorectal cancer

A K Diehl

    The Journal of Family Practice
    |April 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Colorectal cancer screening aims to detect cancers early. Current methods like sigmoidoscopy and stool tests show promise but lack definitive proof of reducing mortality. High-risk individuals should prioritize screening.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Age-related changes in the chemical composition of gallstones.

    International journal of surgical investigation·2003
    Same author

    Beyond the hematocrit and Po2: a symposium on teaching humanities in academic medical centers.

    The American journal of the medical sciences·2000
    Same author

    Cholelithiasis and the insulin resistance syndrome.

    Hepatology (Baltimore, Md.)·2000
    Same author

    Gallstone disease in Mestizo Hispanics.

    Gastroenterology·1998
    Same author

    Gallstone size and risk of pancreatitis.

    Archives of internal medicine·1997
    Same author

    Characteristics of patients with single versus multiple cholesterol gallstones.

    Digestive diseases and sciences·1997
    Same journal

    Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

    The Journal of family practice·2023
    Same journal

    Preventing RSV in children and adults: A vaccine update.

    The Journal of family practice·2023
    Same journal

    Essential oils: How safe? How effective?

    The Journal of family practice·2023
    Same journal

    51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

    The Journal of family practice·2023
    Same journal

    Renewing the dream.

    The Journal of family practice·2023
    Same journal

    55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

    The Journal of family practice·2023
    See all related articles

    Area of Science:

    • Oncology
    • Preventive Medicine
    • Gastroenterology

    Background:

    • Colorectal cancer is a leading cause of death in the US, with a five-year survival rate below 50%.
    • Effective preventive measures are lacking, highlighting the need for early detection strategies.
    • Screening tests offer potential for early diagnosis when prognosis is more favorable.

    Purpose of the Study:

    • To evaluate the effectiveness of current colorectal cancer screening methods in reducing mortality.
    • To provide guidance on appropriate screening practices pending further clinical trial results.

    Main Methods:

    • Review of existing studies on periodic rigid sigmoidoscopy and stool occult blood testing.
    • Analysis of uncontrolled study data indicating cancer detection rates and localization.

    Related Experiment Videos

  • Consideration of National Cancer Institute's consensus recommendations.

    • Main Results:

    • No screening test has definitively proven its effectiveness in reducing colorectal cancer mortality.
    • Rigid sigmoidoscopy and stool occult blood testing detect approximately 2 cancers per 1000 individuals screened.
    • Suggestive evidence indicates these tests may detect more localized cancers.

    Conclusions:

    • Current screening methods lack definitive evidence of mortality reduction.
    • Screening should be limited to high-risk individuals (over 45, family history, polyps).
    • Protocols should prioritize high specificity, with guidelines pending randomized controlled trials.